February 28, 2023
David Wohl, MD, and Billy Fischer, MD, published an op-ed in the News & Observer, The Charlotte Observer, and McClatchy subsidiaries on their work trying to gain a better understanding of COVID-19 through a largely observation study of thousands of volunteers in North Carolina.
February 22, 2023
NIH-supported studies, including one from UNC School of Medicine’s Emily Pfaff, PhD, co-first author of the study, Coding long COVID: characterizing a new disease through an ICD-10 lens, show variations in long COVID symptoms and diagnostic experiences among different racial and ethnic groups.
December 1, 2022
This research in an infant model was led by researchers from the UNC School of Medicine, Weill Cornell Medicine and University of California, Davis. Kristina De Paris, PhD, professor in the UNC Department of Microbiology & Immunology co-led this project.
November 11, 2022
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD, co-lead, the study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes including recovery from acute illness, symptom rebound, re-infection, and long COVID. Investigators explain the study more in video.
July 5, 2022
The Clinical Trials Unit in the UNC Children’s Research Institute is a site for a national study to assess the efficacy of Paxlovid, a pill to treat COVID in children under 18 at increased risk for severe illness.
July 5, 2022
Ke Cheng, PhD, in the Joint UNC-NCSU Joint Department of Biomedical Engineering, in collaboration with colleagues at UNC-Chapel Hill and Duke University, led the development of the vaccine prototype from proof-of-concept to animal studies.
July 1, 2022
William L. Roper, MD, MPH, former dean of the UNC School of Medicine and CEO of UNC Health, wrote an editorial for the journal Science on "the roles of science and politics in public policy decisions, and the means by which scientific truth is established and updated."
June 16, 2022
An independent expert advisory committee recommended 21-0 that the FDA grant emergency use authorization for a fourth COVID-19 vaccine, made by Novavax. Cindy Gay, MD, MPH, discusses the Novavax data, its effectiveness, and how it's different from the other three COVID-19 vaccines.
June 8, 2022
NIH Director's Blog features a UNC-led study on how a well-trained computer and its artificial intelligence can help identify potential Long COVID patients. The study, led by UNC School of Medicine's Emily Pfaff, PhD, was published in the journal The Lancet Digital Health.
May 17, 2022
Melissa Miller, PhD, director of the Clinical Molecular Microbiology Laboratory at UNC Medical Center, talks with the News and Observer about why an at-home COVID test might give false-negative results and tips on how to determine if follow-up testing is needed.
May 16, 2022
A study published in The Lancet Digital Health led by UNC School of Medicine’s Emily R. Pfaff, PhD, shows how the National COVID Cohort Collaborative used XGBoost machine learning models to better define long COVID and identify potential long COVID patients with a high degree of accuracy.
May 3, 2022
Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics, and Ralph Baric, PhD, the William Kenan Distinguished Professor of Epidemiology and Microbiology & Immunology, were elected as members of the American Academy of Arts & Sciences.